Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA-Unresponsive Platinum(II) Complex Induces ERS-Mediated Mitophagy in Cancer Cells
Yan Guo, S. Jin, Hao Yuan, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 520-530
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy
Sisi Wang, Lizhi Gai, Yuncong Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 8, pp. 3976-4019
Closed Access | Times Cited: 50
Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced Anticancer Therapy
Ganghao Liang, Tumpa Sadhukhan, Samya Banerjee, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 22
Open Access | Times Cited: 48
A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption
Yidan Lai, Nong Lu, Shuangling Luo, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13041-13051
Closed Access | Times Cited: 50
Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer
Ming Jiang, Zhenlei Zhang, Wenjuan Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9447-9458
Closed Access | Times Cited: 44
Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents
Ming Zhang, Linming Li, Suying Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3393-3410
Closed Access | Times Cited: 26
Regulating tumor glycometabolism and the immune microenvironment by inhibiting lactate dehydrogenase with platinum(iv) complexes
S. Jin, Enmao Yin, Chenyao Feng, et al.
Chemical Science (2023) Vol. 14, Iss. 31, pp. 8327-8337
Open Access | Times Cited: 23
Synthesis and anticancer mechanisms of zinc(ii)-8-hydroxyquinoline complexes with 1,10-phenanthroline ancillary ligands
Ling-Qi Du, Tianyu Zhang, Xiaomei Huang, et al.
Dalton Transactions (2023) Vol. 52, Iss. 15, pp. 4737-4751
Closed Access | Times Cited: 18
Novel bifluorescent Zn(II)–cryptolepine–cyclen complexes trigger apoptosis induced by nuclear and mitochondrial DNA damage in cisplatin-resistant lung tumor cells
Zhenfeng Wang, Xiaofeng Zhou, Qiao-Chang Wei, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114418-114418
Closed Access | Times Cited: 23
Amlexanox-modified platinum(IV) complex triggers apoptotic and autophagic bimodal death of cancer cells
Yan Guo, S. Jin, Dongfan Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114691-114691
Closed Access | Times Cited: 22
Mechanistic investigation of the cytotoxicity of new Ce(IV) and Zn(II) complexes containing pyridinedicarboxylic acid derivatives against the SW480 cell line
Alireza Aliabadi, Sara Abdolmaleki, Samad Khaksar
Journal of Molecular Structure (2025) Vol. 1319, pp. 139377-139377
Closed Access
Cellular Discrepancy of Platinum Complexes in Interfering with Mitochondrial DNA
S. Jin, Yafeng He, Chenyao Feng, et al.
ACS Central Science (2025)
Open Access
Platinum(II) 5-substituted-8-hydroxyquinoline coordination compounds induces mitophagy-mediated apoptosis in A549/DDP cancer cells
Yan Yang, Ling-Qi Du, Yan Huang, et al.
Journal of Inorganic Biochemistry (2023) Vol. 241, pp. 112152-112152
Closed Access | Times Cited: 12
Antitumor studies evaluation of triphenylphosphine ruthenium complexes with 5,7-dihalo-substituted-8-quinolinoline targeting mitophagy pathways
Zhenfeng Wang, Xiaoqiong Huang, Run-Chun Wu, et al.
Journal of Inorganic Biochemistry (2023) Vol. 248, pp. 112361-112361
Closed Access | Times Cited: 11
Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition
Guandong Zhang, Mengmeng Wang, Yan Su, et al.
Journal of Inorganic Biochemistry (2024) Vol. 256, pp. 112574-112574
Closed Access | Times Cited: 3
Integrated energy conversion units in nanoscale frameworks induce sustained generation and amplified lethality of singlet oxygen in oxidative therapy of tumor
Jing Zhu, Tao Ding, Kaifei Jin, et al.
View (2022) Vol. 3, Iss. 6
Closed Access | Times Cited: 15
Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase
Xinnan Li, Xiaotong Ze, Shengnan Zhou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5118-5153
Closed Access | Times Cited: 8
Hydrazylpyridine salicylaldehyde–copper(ii)–1,10-phenanthroline complexes as potential anticancer agents: synthesis, characterization and anticancer evaluation
Yating Chen, Zhilin Ke, Lingyu Yuan, et al.
Dalton Transactions (2023) Vol. 52, Iss. 35, pp. 12318-12331
Closed Access | Times Cited: 7
8-hydroxyquinoline-N-oxide copper(II)- and zinc(II)-phenanthroline and bipyridine coordination compounds: Design, synthesis, structures, and antitumor evaluation
Ling-Qi Du, Chujie Zeng, Dong-Yin Mo, et al.
Journal of Inorganic Biochemistry (2023) Vol. 251, pp. 112443-112443
Closed Access | Times Cited: 7
A monofunctional Pt(ii) complex combats triple negative breast cancer by triggering lysosome-dependent cell death
Xiaomin Shen, Yue Peng, Zidong Yang, et al.
Dalton Transactions (2024) Vol. 53, Iss. 8, pp. 3808-3817
Closed Access | Times Cited: 2
Anticancer activity of 8-hydroxyquinoline-triphenylphosphine rhodium(III) complexes targeting mitophagy pathways
Xiaoqiong Huang, Run-Chun Wu, Jianmin Liang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116478-116478
Closed Access | Times Cited: 2
Novel zinc(II)−curcumin molecular probes bearing berberine and jatrorrhizine derivatives as potential mitochondria-targeting anti-neoplastic drugs
Shu‐Hua Zhang, Zhenfeng Wang, Haijun Tan
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114736-114736
Closed Access | Times Cited: 11
Synthesis and anticancer mechanisms of nickel(II)-2-amino-8-quinolinol complexes with 2,2′-bipyridine ancillary ligands
Zhen Zhou, Ling-Qi Du, Dong- Yin Mo, et al.
Inorganic Chemistry Communications (2023) Vol. 152, pp. 110712-110712
Closed Access | Times Cited: 6
Chlorquinaldol-zinc(II)-bipyridine complexes: Design, synthesis, structure and anticancer evaluation
Ling-Qi Du, Zhao‐Xu Chen, Qiao-Chang Wei, et al.
Inorganic Chemistry Communications (2023) Vol. 156, pp. 111238-111238
Closed Access | Times Cited: 6
Platinum-based drugs and hydrogel: a promising anti-tumor combination
Jiamin Yao, Shaojuan Song, Hang Zhao, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Novel glycosylation zinc(II)–cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells
Zhen Zhou, Ling-Qi Du, Xiaomei Huang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114743-114743
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top